Global Breast Cancer Imaging Market Research Report Insights, Opportunity Analysis, Market Shares and Forecast, 2017 - 2023

  • ID: 4412863
  • Report
  • Region: Global
  • 190 Pages
  • Occams Business Research and Consulting
1 of 4
The Global Breast Imaging Market is Expected to Grow at a CAGR of 8.5% During 2016-2023.

FEATURED COMPANIES

  • Carestream Health
  • Dilon Technologies, Inc.
  • Gamma Medica , Inc
  • Hologic , Inc.
  • Philips Healthcare
  • Siemens Healthcare
  • MORE

Breast imaging technology is generally used for the detection of cancer cells in women who have abnormal mammograms. Some of the breast imaging techniques is diagnostics ultrasound, breast MRI and full-field digital mammography. Key trends boosting the growth for the global breast imaging market are various technological advancements in breast cancer detection and emergence of microwave tomography imaging. The global breast imaging market is mainly driven by rising prevalence of breast cancer, rising awareness about early detection of breast cancer, government investments and funding for breast cancer treatment and related research , rapidly increasing aging population. various technological advancements in breast imaging techniques and launch of advanced systems capable of detection cancer in women with dense breast tissue. Some prominent restraints for the breast imaging market are side effects of radiation exposure, high installation costs of breast imaging system, unfavorable reimbursements scenario in developing countries and errors in breast cancer screening and diagnosis. Key challenge for the global breast imaging market is stringent regulatory approval procedures, and to overcome this challenge various market opportunities present in the market are emerging economies offer high growth potential and technological innovations for detection of breast cancer detection.

Global breast imaging market report covers segmentation analysis by its type. Report covers further segments of its type which are ionizing technologies and non-ionizing technologies. Geographically, North America is anticipated to hold highest market share in terms of revenue in 2016 , factors  responsible for growth are rising incidence of breast cancer, ongoing technological advancements in this region and rapid growth in the geriatric population and application of new breast density notification law in US .. Moreover, Asia-Pacific is expected to be the fastest growing region during the forecasted period of 2016-2023. Factors that are responsible for the growth in this region are rising healthcare expenditure, rising patient population.

Some of the key playersof the global Breast Imaging market are GE Healthcare (United Kingdom), Siemens Healthcare (Germany), Hologic, Inc (United States), Philips Healthcare (Netherlands), Toshiba Corporation (Japan), Fujifilm Holdings Corporation (Japan), Gamma Medica, Inc. (United States). These companies are using various strategies such as merger & acquisitions, collaboration, partnership and product launch to hold large market share.



Note:
Please allow up to 72 hours for delivery.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Carestream Health
  • Dilon Technologies, Inc.
  • Gamma Medica , Inc
  • Hologic , Inc.
  • Philips Healthcare
  • Siemens Healthcare
  • MORE

1. Introduction
1.1. Executive Summary
1.2. Estimation Methodology
 
2. Market Overview
2.1. Global Breast Cancer Imaging Market : Evolution & Transition
2.2. Market Definition & Scope
2.3. Industry Structure
2.4. Total Market Analysis
2.4.1. Top 5 Findings
2.4.2. Top 5 Opportunity Markets
2.4.3. Top 5 Companies
2.4.4. Top 3 Competitive Strategies
2.5. Estimation Analysis
2.6. Strategic Analysis
2.6.1. Investment Vs. Adoption Model
2.6.2. 360 Degree Industry Analysis
2.6.3. Porters 5 Force Model
2.6.4. See-Saw Analysis
2.6.5. Patent Analysis
2.6.6. Pipeline Analysis
2.6.7. Consumer Analysis And Key Buying Criteria
2.7. Competitive Analysis
2.7.1. Key Strategies & Analysis
2.7.2. Market Share Analysis & Top Company Analysis
2.8. Strategic Recommendations & Key Conclusions
2.8.1. Investment Opportunities By Regions
2.8.2. Opportunities in Emerging Applications
2.8.3. Investment Opportunity in Fastest Growing Segment
 
3. Market Determinants
3.1. Market Drivers
3.1.1. Rising Prevalence of Breast Cancer
3.1.2. Increasing Awareness About Early Detection of Breast Cancer
3.1.3. Government Investments And Funding for Breast Cancer Treatment And Related Research
3.1.4. Rapidly Increasing Aging Population
3.1.5. Launch of Advanced Systems Capable of Detecting Cancer In Women With Dense Breast Tissue
3.1.6. Technological Advancements in Breast Cancer Imaging Modalities
3.2. Market Restraints
3.2.1. Side Effects of Radiation Exposure
3.2.2. High Installation Costs of Breast Cancer Imaging Systems
3.2.3. Errors in Breast Cancer Screening And Diagnosis
3.2.4. Unfavorable Reimbursement Scenario in Developing Countries
3.3. Market Opportunities
3.3.1. Technological Innovations in Breast Cancer Detection
3.3.2. Emerging Economies Offer High Growth Potential
3.4.   Market Challenges
3.4.1. Stringent Regulatory Approval Procedures
 
4. Market Segmentation
4.1. Global Breast Cancer Imaging Market  By Type
4.1.1. Market Definition And Scope
4.1.2. Decision Support Database & Estimation Methodology
4.1.3. Comparative Analysis Across Market Segments
4.1.4.  Opportunity Matrix
4.1.5. Market Segmentation
4.1.5.1. Global Ionizing Technologies  Market
4.1.5.1.1. Adoption Scenario & Market Determinants
4.1.5.1.2. Market Estimations And Forecasts 2014-2023 ($ Million)
4.1.5.1.3. Key Players & Key Products
4.1.5.1.4. Key Conclusions
4.1.5.1.5. Sub Segments
4.1.5.1.5.1. 3D Breast Tomosynthesis
4.1.5.1.5.2. Analog Mammography
4.1.5.1.5.3. Cone-Beam Computed Tomography (Cbct)
4.1.5.1.5.4. Electric Impedance Tomography
4.1.5.1.5.5. Full-Field Digital Mammography (Ffdm)
4.1.5.1.5.6. Molecular Breast-Specific Gamma Imaging (Mbi/Bsgi)
4.1.5.1.5.7. Positron Emission Mammography (Pem)
4.1.5.1.5.8. Positron Emission Tomography And Computed Tomography (Pet-Ct)
4.1.5.2. Global Non-Ionizing Technologies  Market
4.1.5.2.1. Adoption Scenario & Market Determinants
4.1.5.2.2. Market Estimations And Forecasts 2014-2023 ($ Million)
4.1.5.2.3. Key Players & Key Products
4.1.5.2.4. Key Conclusions
4.1.5.2.5. Sub Segments
4.1.5.2.5.1. Automated Whole-Breast Ultrasound (Awbu)
4.1.5.2.5.2. Breast Mri
4.1.5.2.5.3. Breast Thermography
4.1.5.2.5.4. Breast Ultrasound
4.1.5.2.5.5. Optical Imaging
 
5. Competitive Landscape
5.1. Key Strategies
5.1.1. List of Merger & Acquisition
5.1.2. List of Joint Venture
5.1.3. List of Product Launches
5.1.4. List of Partnership
 
6. Geographical Analysis
6.1. Decision Support Database & Estimation Methodology
6.2. Comparative Analysis Across Market Segments
6.3. Opportunity Matrix
6.4.  Global Breast Cancer Imaging Market  By Region 2014-2023 ($ Million)
6.4.1. North America
6.4.1.1. Industry Analysis 2014-2023 ($ Million)
6.4.1.2. Top Country Analysis
6.4.1.2.1. U.S.
6.4.1.2.1.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.1.2.1.2. Key Players & Key Products
6.4.1.2.1.3. Key Conclusions
6.4.1.2.2. Canada
6.4.1.2.2.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.1.2.2.2. Key Players & Key Products
6.4.1.2.2.3. Key Conclusions
6.4.2. Europe
6.4.2.1. Industry Analysis 2014-2023 ($ Million)
6.4.2.2. Top Country Analysis
6.4.2.2.1. Uk
6.4.2.2.1.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.2.2.1.2. Key Players & Key Products
6.4.2.2.1.3. Key Conclusions
6.4.2.2.2. France
6.4.2.2.2.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.2.2.2.2. Key Players & Key Products
6.4.2.2.2.3. Key Conclusions
6.4.2.2.3. Germany
6.4.2.2.3.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.2.2.3.2. Key Players & Key Products
6.4.2.2.3.3. Key Conclusions
6.4.2.2.4. Russia
6.4.2.2.4.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.2.2.4.2. Key Players & Key Products
6.4.2.2.4.3. Key Conclusions
6.4.2.2.5. Rest of Europe
6.4.2.2.5.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.2.2.5.2. Key Players & Key Products
6.4.2.2.5.3. Key Conclusions
6.4.3. Asia Pacific
6.4.3.1. Industry Analysis 2014-2023 ($ Million)
6.4.3.2. Top Country Analysis
6.4.3.2.1. China
6.4.3.2.1.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.3.2.1.2. Key Players & Key Products
6.4.3.2.1.3. Key Conclusions
6.4.3.2.2. India
6.4.3.2.2.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.3.2.2.2. Key Players & Key Products
6.4.3.2.2.3. Key Conclusions
6.4.3.2.3. Japan
6.4.3.2.3.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.3.2.3.2. Key Players & Key Products
6.4.3.2.3.3. Key Conclusions
6.4.3.2.4. Australia
6.4.3.2.4.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.3.2.4.2. Key Players & Key Products
6.4.3.2.4.3. Key Conclusions
6.4.3.2.5. Rest of Asia Pacific
6.4.3.2.5.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.3.2.5.2. Key Players & Key Products
6.4.3.2.5.3. Key Conclusions
6.4.4. Row
6.4.4.1. Industry Analysis 2014-2023 ($ Million)
6.4.4.2. Top Country Analysis
6.4.4.2.1. Latin America
6.4.4.2.1.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.4.2.1.2. Key Players & Key Products
6.4.4.2.1.3. Key Conclusions
6.4.4.2.2. Middle East & Africa
6.4.4.2.2.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.4.2.2.2. Key Players & Key Products
6.4.4.2.2.3. Key Conclusions
 
7. Company Profiles
7.1. Hologic , Inc.
7.1.1. Overview
7.1.2. Product Portfolio
7.1.3. Strategic Initiatives
7.1.4. Scot Analysis
7.1.5. Strategic Analysis
7.2. Ge Healthcare
7.2.1. Overview
7.2.2. Product Portfolio
7.2.3. Strategic Initiatives
7.2.4. Scot Analysis
7.2.5. Strategic Analysis
7.3. Siemens Healthcare
7.3.1. Overview
7.3.2. Product Portfolio
7.3.3. Strategic Initiatives
7.3.4. Scot Analysis
7.3.5. Strategic Analysis
7.4.  Philips Healthcare
7.4.1. Overview
7.4.2. Product Portfolio
7.4.3. Strategic Initiatives
7.4.4. Scot Analysis
7.4.5. Strategic Analysis
7.5. Fujiflim Healthcare
7.5.1. Overview
7.5.2. Product Portfolio
7.5.3. Strategic Initiatives
7.5.4. Scot Analysis
7.5.5. Strategic Analysis
7.6. Toshiba Corporation
7.6.1. Overview
7.6.2. Product Portfolio
7.6.3. Strategic Initiatives
7.6.4. Scot Analysis
7.6.5. Strategic Analysis
7.7. Gamma Medica , Inc
7.7.1. Overview
7.7.2. Product Portfolio
7.7.3. Strategic Initiatives
7.7.4. Scot Analysis
7.7.5. Strategic Analysis
7.8. Aurora Imaging Technology, Inc.
7.8.1. Overview
7.8.2. Product Portfolio
7.8.3. Strategic Initiatives
7.8.4. Scot Analysis
7.8.5. Strategic Analysis
7.9. Sonocine , Inc.
7.9.1. Overview
7.9.2. Product Portfolio
7.9.3. Strategic Initiatives
7.9.4. Scot Analysis
7.9.5. Strategic Analysis
7.10. Dilon Technologies, Inc.
7.10.1. Overview
7.10.2. Product Portfolio
7.10.3. Strategic Initiatives
7.10.4. Scot Analysis
7.10.5. Strategic Analysis
7.11. Shimadzu Corporation
7.11.1. Overview
7.11.2. Product Portfolio
7.11.3. Strategic Initiatives
7.11.4. Scot Analysis
7.11.5. Strategic Analysis
7.12. Carestream Health
7.12.1. Overview
7.12.2. Product Portfolio
7.12.3. Strategic Initiatives
7.12.4. Scot Analysis
7.12.5. Strategic Analysis
7.13. Hitachi Medical Corporation
7.13.1. Overview
7.13.2. Product Portfolio
7.13.3. Strategic Initiatives
7.13.4. Scot Analysis
7.13.5. Strategic Analysis
7.14. Medtronics
7.14.1. Overview
7.14.2. Product Portfolio
7.14.3. Strategic Initiatives
7.14.4. Scot Analysis
7.14.5. Strategic Analysis
7.15. Cook Medical
7.15.1. Overview
7.15.2. Product Portfolio
7.15.3. Strategic Initiatives
7.15.4. Scot Analysis
7.15.5. Strategic Analysis
 
List of Tables
1. Global Breast Cancer Imaging Market  By  Type  2014-2023 ($ Million)
2. Global Ionizing Technologies  Market By Geography 2014-2023 ($ Million)
3. Global Non-Ionizing Technologies  Market By Geography 2014-2023 ($ Million)
4. North America Breast Cancer Imaging Market 2014-2023 ($ Million)
5. Europe Breast Cancer Imaging Market 2014-2023 ($ Million)
6. Asia Pacific Breast Cancer Imaging Market 2014-2023 ($ Million)
7. Rest of the World Breast Cancer Imaging Market 2014-2023 ($ Million)
 
List of Figures
1. Global Ionizing Technologies  Market 2014-2023 ($ Million)
2. Global Non-Ionizing Technologies Market 2014-2023 ($ Million)
3. United States (U.S.) Breast Cancer Imaging Market 2014-2023 ($ Million)
4. Canada Breast Cancer Imaging Market 2014-2023 ($ Million)
5. United Kingdom (Uk) Breast Cancer Imaging Market 2014-2023 ($ Million)
6. France Breast Cancer Imaging Market 2014-2023 ($ Million)
7. Germany Breast Cancer Imaging Market 2014-2023 ($ Million)
8. Russia Breast Cancer Imaging Market 2014-2023 ($ Million)
9. Roe Breast Cancer Imaging Market 2014-2023 ($ Million)
10. India Breast Cancer Imaging Market 2014-2023 ($ Million)
11. China Breast Cancer Imaging Market 2014-2023 ($ Million)
12. Japan Breast Cancer Imaging Market 2014-2023 ($ Million)
13. Australia Breast Cancer Imaging Market 2014-2023 ($ Million)
14. Roapac Breast Cancer Imaging Market 2014-2023 ($ Million)
15. Latin Breast Cancer Imaging Market 2014-2023 ($ Million)
16. Mena Breast Cancer Imaging Market 2014-2023 ($ Million)

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Aurora Imaging Technology, Inc.
  • Carestream Health
  • Cook Medical
  • Dilon Technologies, Inc.
  • Fujiflim Healthcare
  • Gamma Medica , Inc
  • Ge Healthcare
  • Hitachi Medical Corporation
  • Hologic , Inc.
  • Medtronics
  • Philips Healthcare
  • Shimadzu Corporation
  • Siemens Healthcare
  • Sonocine , Inc.
  • Toshiba Corporation
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll